chrisvoncsefalvay/vaers-outcomes huggingface dataset:
shortness of breath; cough; Low blood pressure; Flu like symptoms; Headache; fever; pain; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of HYPOTENSION (Low blood pressure), INFLUENZA LIKE ILLNESS (Flu like symptoms), HEADACHE (Headache), PYREXIA (fever) and PAIN (pain) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included SALBUTAMOL (ALBUTEROL HFA) and BECLOMETASONE DIPROPIONATE (QVAR) for Asthma.    On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced HYPOTENSION (Low blood pressure), INFLUENZA LIKE ILLNESS (Flu like symptoms), HEADACHE (Headache), PYREXIA (fever), PAIN (pain) and NAUSEA (Nausea). On 07-Mar-2021, the patient experienced DYSPNOEA (shortness of breath) and COUGH (cough). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) for Headache, at an unspecified dose and frequency and NAPROXEN SODIUM (ALEVE) for Headache, at an unspecified dose and frequency. On 05-Mar-2021, NAUSEA (Nausea) outcome was unknown. On 06-Mar-2021, HEADACHE (Headache) and PYREXIA (fever) outcome was unknown. At the time of the report, HYPOTENSION (Low blood pressure), INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN (pain), DYSPNOEA (shortness of breath) and COUGH (cough) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Mar-2021, Blood pressure measurement: 90/60 (Low) 90/60.          Treatment includes salt intake to increase   This case was linked to MOD-2021-116640 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: NNI On 07-May-2021: Updated address of reporter.
Information regarding PREVNAR was received from a healthcare professional regarding a patient who was administered the vaccine that was stored with a temperature of 33 degrees for one hour.  The patient received a dose on an unspecified date.  The patient was administered the PREVNAR vaccine that was stored at a temperature of 33 degrees for one hour.  No additional information was available at the time of this report.
pt recv vax & devel an inj site rxn characterized by redness, swelling & soreness w/in 24hr of vax;this is 1 of 4 pt from this facility to devel a rxn p/vax;
died; tested positive for covid; tested positive for covid; This is a spontaneous report from a non-contactable consumer. This male patient of unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. Medical history included chronic lymphocytic leukemia untreated since 2018 or 2019. Concomitant medications were not provided. It was reported that on unspecified date, patient got BNT162B2 and later tested positive for covid and died. It was not reported if an autopsy was performed. Lab data included covid test was positive on unspecified date. The outcome of the event died was fatal, while of the other events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: died
Patient felt pain with touch. No problems/pain with movement.  Started swelling with redness and warmth to touch.  A day later felt knot and tightness at the site.  Came to pharmacy on 4/11/23, swelling and area of redness had decreased.  Patient has been taking ibuprofen and using cold pack for pain and inflamation.
dizzy,pale from 11:00-12:00, then shortness of breath with increased rate of respirations, headache began which lasted rest of the day, had very weird/strange dreams that night
Information has been received from a licensed practical nurse concerning a pt over 40 yrs old who on approx 10/24/05 was vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine (lot 651523/0604R). ON approx 10/24/05, the pt experienced a more extreme reaction than usual which included extreme soreness, redness, pain and swelling at the injection site and limb and site tenderness. Unspecified medical attention was sought. Subsequently, the pt recovered. It was noted that the pt did not have a reaction to the initial vaccination of Pneumococcal 23v polysaccharide vaccine. A investigation into the lot number was requested. No product quality complaint was involved. The records of testing prior to release of this lot have been checked and found to be satisfactory. The lot complies with the standards and was released. Additional information has been requested.
Patient developed a rash around injection site two days after receiving hepatitis A vaccine. As of 7/06/07 rash remains visible. No other symptoms noted.
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently 90-year-old patient of unknown gender. No information was received regarding medical history, concurrent conditions, or concomitant medications.   On an unknown date in 2014, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, dose, route of administration, lot number and expiration date were not reported) for the long-term prevention of shingles and zoster-related conditions. On an unknown date, the patient experienced shingles. The outcome of the event was not reported. The event of shingles was resulting from zoster vaccine live (ZOSTAVAX).
A metallic taste when through my mouth & got my mouth dry as soon as they where putting the vaccination. Then I got a really bad headache & very nauseas within 5 min of getting the vaccine. I had pain on the vaccine area. I also felt very tired very exhausted about 4 or 5hrs later. I started getting chills & achiness started the next day on 12/24/2020. On 12/25/2020 I felt nauseas, still had the chills, headaches, still felt fatigue, achiness, sore throat & also had diarrhea. I had all this symptoms all the way till 12/29/2020.       Seen doctor on 12/28/2020 and they decided I should get tested for Covid.
2nd dose of Moderna was given to early.  First dose was given on 5/13/21 and the second dose was given on 5/29/21
Pt reports swelling, redness and lumps appeared and lasted the weekend. States arm is feeling much better now
Dizziness, diaphoresis, tiredness, weakness, nausea started within a minute after immunization lasted for about an hour; Treatment was pt. laid down and sips of water.
I stared getting respiratory issues that turned into pneumonia and from that I have developed severe asthma and constant shortness of breath. I tire easily and can?t even talk for long periods of time. My fibromyalgia pain is much worse and my brain fog is also much worse. I have more numbness and tingling.
"Itchy rash started on friday x 5 days 3 hours after I received a Shingles  shot. On the 2nd day, it was also on both his L leg blotches. L arm was swollen  & little warm, went to pharmacy & told me to take Benadryl which cleared the  rash up. But the next day, rash showed up again & it went away after I took  couple Benadryl & that's it. The rash has NOT come back since."
Period is a week early, heavier and more painful than normal. I'm more fatigued this menstrual cycle and have had more headaches
Shakes, Chills, Fever, Sweats, Body Aches, Swollen injection site and redness/rash at injection site.
U07.1 - COVID-19 J12.82 - Pneumonia due to Coronavirus disease 2019
Employee developed pain in her right arm following flu vaccination. By 12:00pm she developed a headache. She took Tylenol and said it did not touch her headache. At 1:30pm she started feeling dizzy and by 2:00pm she was nauseous. At this time, she left work early to go home and go to bed. Employee stated her headache did ease up, but movement would exacerbate the nausea. On 10/22/20 she was feeling better but a residual headache remained.
5 cm warm raised area on (R) deltoid over injection site. Complains of itchy and soreness.
Patient received his first dose back in January (he has not received a second dose yet) More than 36 days have passed since first dose received; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient received his first dose back in January (he has not received a second dose yet) More than 36 days have passed since first dose received) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient received his first dose back in January (he has not received a second dose yet) More than 36 days have passed since first dose received). In January 2021, PRODUCT DOSE OMISSION ISSUE (Patient received his first dose back in January (he has not received a second dose yet) More than 36 days have passed since first dose received) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication history not provided. Treatment information was unknown.
Fever, stomach pain, diarrhea, pale, sore arm, lump in arm. This evidently happened with 1st, but never reported by Mom.
Achyiess began 1 hour after immunization. Progressed to fever of 103 F, dyspnea, sore throat, cough, congestion, body aches.
I noticed dry skin and small dots of blood under the skin at the area of injection 4 days after my first COVID-19 vaccine injection. The area is not itchy or painful and the overall area was approximately a .25in x .33in.  The symptoms were not present before then.   I have a photo of the area/adverse reaction that I can provide for documentation.
Patient received Janssen COVID vaccine on 3/13/21 at an outside facility. Patient recently attended a family reunion. On 8/17/21, patient admitted to our Medical Center for COVID pneumonia with acute respiratory failure/hypoxia. As of 8/20/21 (today), patient is still admitted in the med/surg unit.
cold; Shaking; Chills; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (cold), TREMOR (Shaking) and CHILLS (Chills) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20N and 024M20N) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced NASOPHARYNGITIS (cold), TREMOR (Shaking) and CHILLS (Chills). On 20-Feb-2021, NASOPHARYNGITIS (cold), TREMOR (Shaking) and CHILLS (Chills) had resolved.            No concomitant medication was reported.  No treatment medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2021: Follow -up received and contains no new information
Pt received a covid vaccine on 9-23-21.  Injection was at the right deltoid.  Pt noted a small bump at his right bicep on 10-1-21.  Unclear if it is related.  Appears consistent with a small lymph node.  Doubt clinically significant, but will monitor over time.
Patient began feeling weakness in his legs and slowly became unable to walk. He was driven to the ER by his parent.
12/17/09 24-48 hr after receiving TIV at clinic (TIV), began to have red non-itchy rash to backs of legs & stomach. Saw PCP on 12/9/09, put on CLARITIN & topical cream & rash completely gone by 12/15/09.
This spontaneous report as received from a registered nurse and refers to three patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On 17-JAN-2017, the patients were vaccinated with improperly stored doses of GARDASIL 9 lot # M034780, expiration date 15-04-2019 (dose and route of administration were not reported). There was no adverse effect reported. Administered doses of vaccines experienced the temperature excursion between 32 degrees Fahrenheit and 36 degrees Fahrenheit for 2 hours and 30 minutes and below 32 degrees Fahrenheit for 30 minutes. Data logger was involved. There were no previous excursions reported. No product quality complaint was involved. Additional information has been requested.
Proteinuria; This is a spontaneous report from contactable consumer. This consumer reported similar events for 2 patients. This report is for 2nd of 2 patient.  A 53-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: not reported, Expiry date: not reported) via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID- 19 Immunization. The patient medical history and concomitant medications were not reported. Reporter stated that she knew another person who got the shot and now had too much protein in their blood work on an unspecified date. It's called proteinuria. Reporter clarified that she was an insurance agent and Someone else (not her husband) just got declined health insurance because there was too much protein in his blood although he was perfectly healthy. She knew there was positives but to have someone have to too protein and their protein spike. That sent a red flag in her opinion. Patient underwent lab test and procedures on an unspecified date which included blood work: too much protein. Outcome of the event was unknown.  The lot number for the vaccine, [BNT162B2] was not provided and will be requested during follow-up.  Lot/batch number was not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
48 hours after administration, patient experienced 2 red raised bumps about 2 inches aware from the injection site,
Appendicitis with resulting appendectomy Appendicitis symptoms started at 6pm on 3/20/2021 Confirmed appendicitis at Emergency Room on 3/21/2021 at 12pm  Laparoscopic appendectomy at 7:30pm 3/21/2021
Pt reports arm starting to hurt within 3-4 hours of administration. He reports losing all strength in his arm and having weakness and trouble lifting things. He came in today 4/20/15 to report this and says the pain is subsiding and he is using a sling to support the arm. He says he did not need to take any additional pain medication that he already has on hand for another condition. He says he will follow up with his MD.
AFTER RECEIVING THE VACCINE HE COMPLAINED OF STABBING CHEST PAIN. ON SITE EMS RESPONDED. HE WAS TAKEN TO THE AMBULANCE FOR AN EKG. IT WAS RECOMMENDED TO GO TO THE HOSPITAL BY AMBULANCE, BUT HE REFUSED AND LEFT AGAINST MEDICAL ADVISE. I WASN'T ABLE TO GET ANY VITALS FROM EMS.
Patient is a 60-year-old female with past medical history of HTN, SLE presents emergency department with throat itching after receiving the COVID-19 vaccination.  Patient states that she previously had allergic reaction to contrast dye in the past and is having a similar sensation in her throat.  She admits to nausea but denies any voice changes, difficulty swallowing, wheezing, rash.  Patient denies requiring admission recommendation from allergic reaction past.  Patient received Allegra prior to receiving the vaccination.  This is her first dose of the vaccination.
This spontaneous report as received from a physician via a company representative, refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 18-AUG-2015, the patient was vaccinated with an improperly stored dose of GARDASIL 9 "0.5mL-10 Pk SD PFS-Luer-Lok" which had a lot number of L001312 and expiration date of 24-FEB-2017 (route of administration and anatomical location were not reported). There were no concomitant medications provided. No adverse effects reported. No product quality complaint was involved. On an unspecified dates, the GARDASIL 9 vaccine had two temperature excursions; one of 24 hours and other one of 32 hours. The lowest recorded temperature was 34 F (1.111111111 Celsius) and the highest recorded temperature was 48 F (8.888888889 Celsius).  The vaccine status was reported as "in excursion". The vaccine storage criteria and the vaccine excursion were reported as "Refrigerator (R)". This is one of several cases from the same reporter. Additional information has been requested.
Pt recv vax on unknown day;  post vax pt exp passing out x 5 min
Since receiving the first dose of the Moderna Covid-19 vaccination two weeks ago, I have had profuse sweating while I am sleeping. This is not normal for me, and the sweating is so bad that I have had to physically wipe it off of my whole body with a towel. Taking ibuprofen before laying down has no affect on this.
Rec'd vaccine approx. 12:00 noon on 5/22/06. Remained at HD X 15 min. Approx. 13:30, began having mild to moderate H/A over forehead. Took ibuprofen last night. H/A relieved. Other associated symptoms were lightheadedness, weakness and loss of appetite. No longer lightheaded but weakness and loss of appetite persist. Mild symptoms remained.
Redness, swelling, mild tenderness at injection site 5.5cm erythema.
High fever of 102.5 occured seven hours after shot was given. Fever of 100-102.5 occured over next 24 hours. Body aches, paleness and fast heart beat.  Child had no appetite and very little thirst. Child was extremely fatigued and seemed delirious at times.  Tylenol was given at times throughout the day to reduce fever.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for Covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: INFLUENZA (non-serious), outcome "unknown", described as "bad flu". Additional information: Patient thanked Pfizer for Covid vaccine which saved life. Patient had just struggled with the equivalent of a bad flu. This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Started feel heart fluttery sporadically. Waited to go to the doctor as didn't want to over react. Doctor gave me an EKG and put me on a Zio Patch to record my heart beats. There were times that I would wake up in the middle of the night. After reading the results my doctor put me on Metoprolol.  Doing much better after taking Metoprolol.
First dose on July 2020, didn´t received 2nd dose; This case was reported by a nurse via call center representative and described the occurrence of incomplete course of vaccination in a 67-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on July 2020).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The patient didn´t received second dose of shingrix at the time of reporting which led to incomplete course of vaccination.  The reporter consented to follow up.
rash on his arm/has grown and was now a little bit itchy; This is a spontaneous report from a contactable Physician (patient). A 39-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number EK5730, expiry date unknown) intramuscular at right arm on 20Dec2020 around 09:30 at single dose for Covid-19 vaccination. The patient's medical history and concomitant medications were none. The patient received Covid 19 vaccine 8 days ago (20Dec2020 around 09:30) and 5 days ago (Dec2020) he noticed a rash on his arm. The patient informed that he was not even sure if this was about the COVID-19 vaccine or if he has just associated it with it, but the rash has grown and was now a little bit itchy (Dec2020). The patient clarified that his first dose of the COVID-19 vaccine was on 20Dec2020 and he had onset of rash about 23Dec2020 or 24Dec2020, he was not exactly sure. The outcome of the event rash on his arm/has grown and was now a little bit itchy was not recovered. The reporter causality was unknown, with the information he has obtained and the conversation he just had with the inbound transfer agent it seemed a very low, slight likelihood that there was a causality relationship.
I had the pfizer vaccine dose 1 on 18/21 and second dose 1/27/21. I had covid Dec 2 2020.  my covid symptoms werevery  mild.  I had anosmia for 2 days.  I had a fever of 101.5 on Dec 5 2020. I ran on the treadmill and lifted weights every day while on my covid quarantine.    Shortly after the first dose (4-6 hours) of my pfizer vaccine I had body aches, chills, and severe fatigue. this lasted two days.  4-5 hours after my second dose on 1/27/21 I had similar symptoms,  I did have chest pain that I believed to be acid reflux and was seen by a cardiologist in late April because my father has a congenital heart issue and wanted to be sure my chest pain was not cardiac in nature.  I did have an echo 4/27/21 which showed of 40-50% with global hypokinesis. The cardiologist diagnosed me with cardiomyopathy. Then cardiac MRI 5/5/21 which showed EF 49% with global hypokinesis. I then had a stress echo on 8/12/21 which showed resolution , normal wall motion and resting EF of 55-60%.  My cardiologist told me that my cardiomyopathy was possibly from covid. My concern is that my most significant symptoms and fatigue were only after the vaccine.
Please note:   The vaccination record I received with lot number is very difficult to read!!!  My first vaccination was 12/31/20 and lot number written down but hard to read is (U37K2OA but could be V37K20A) The second shot was 1/27/21 and lot number written down could be (0412OA, or could read O912OA!)  I had symptoms of a Pulmonary embolism while cross country skiing March 18 and officially diagnosed with PE on March 22, 2021.  I was tested for Covid 19 on March 23, 2021 with negative results.  I had been reporting my side effects (which were none) for the previous 6 weeks following the second vaccination. I did have cramping like feeling in my right calf following a x-country ski weekend about 4 weeks prior  to the actual PE (2/22/21) but it appeared to resolve after about 7-10 days